Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870

+44 7868 792050

Hazan Sabine

Department of Gastroenterology, ProgenaBiome, Ventura, California, United States

  • Case Report   
    Fecal Microbiota Transplant for the Treatment of Metastatic Mesothelioma: A Case Report
    Author(s): Hazan Sabine*

    Malignant Pleural Mesothelioma (MPM) is a highly aggressive and almost universally fatal neoplasm with limited treatment options. The role of the programmed cell death protein 1 (PD-1) pathway has garnered attention due to its role in eliciting the immune checkpoint response of T cells, resulting in evasion of tumor cells from immune surveillance and chemotherapy resistance. Although, PD-1 checkpoint inhibitors have achieved success in various malignancies, resistance is common. Recently, the role of the gut microbiome in immunomodulation and response to cancer treatment has been recognized. We report a 70-year old female with stage 4 MPM who experienced restoration of therapeutic efficacy and prolonged survival with FMT and pembrolizumab despite prior antibiotic treatment, which is known to attenuate response... View More»
    DOI: 10.35248/2167-0870.21.11.484

    Abstract HTML PDF